Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Christina Bemrich-Stolz
Assistant Professor
Close
E-mail
veggie@uab.edu
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Christina Bemrich-Stolz
Assistant Professor
Positions
Assistant Professor (P)
,
Pediatric - Hematology-Oncology
,
Pediatrics
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2018
Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis
.
Pediatric Blood and Cancer
. 65.
2018
2018
Red blood cell transfusion therapy for sickle cell patients with frequent painful events
.
Pediatric Blood and Cancer
. 65.
2018
2018
Outcomes in mild to moderate isolated thrombocytopenia
.
Pediatrics
. 142.
2018
2016
A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis
.
Journal of Immunology
. 196:2492-2503.
2016
2015
Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia
.
Journal of Blood Medicine
. 6:285-290.
2015
2015
Health-related quality of life in infants with sickle cell disease
.
Journal of Pediatric Hematology/Oncology
. 37:590-594.
2015
2015
Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease
.
Journal of Neurosurgery: Pediatrics
. 16:64-73.
2015
2015
Exploring Adult Care Experiences and Barriers to Transition in Adult Patients with Sickle Cell Disease.
.
International journal of hematology & therapy
. 1.
2015
2015
Patient-centered approach to designing sickle cell transition education
.
Journal of Pediatric Hematology/Oncology
. 37:43-47.
2015
2014
PedsQL™ multidimensional fatigue scale in sickle cell disease: Feasibility, reliability, and validity
.
Pediatric Blood and Cancer
. 61:171-177.
2014
2013
PedsQL™ sickle cell disease module: Feasibility, reliability, and validity
.
Pediatric Blood and Cancer
. 60:1338-1344.
2013
2012
Barriers in transition from pediatrics to adult medicine in sickle cell anemia.
.
Journal of Blood Medicine
. 3:105-112.
2012
2012
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.
.
Arthritis and Rheumatism
. 64:1263-1271.
2012
2010
Single institution series of nodular fasciitis in children
.
Journal of Pediatric Hematology/Oncology
. 32:354-357.
2010
Research
Principal Investigator On
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
awarded by
HEMOPHILIA OF GEORGIA
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
awarded by
HEMOPHILIA OF GEORGIA
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
awarded by
HEMOPHILIA OF GEORGIA
Investigator On
A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
AAML 1031 - A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD
awarded by
CHILDREN'S ONCOLOGY GROUP
AAML 1031 - Bayer
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
AHOD1331 A Randomized Phase III Study of Brentuximab Vedotin (IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
Adaptive Immunity and Persistent SARS-CoV-2 Replication
awarded by
National Cancer Institute/NIH/DHHS
BIQSFP-COG AALL1131 11XS189 Per Case Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
CTSU: Phase II Supplemental Payments (N02-CM-62212)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
NAPAAC Registry Study of Bone Marrow Failure and Myelodysplastic Syndromes
awarded by
BOSTON CHILDREN'S HOSPITAL
Novel Methods to Detect Gene-Environment Interactions in Treatment-Related Brain Tumors Among Childhood Cancer Survivors
awarded by
University of Wisconsin-Milwaukee
PER CASE REIMBURSEMENT NCORP Operations Grant 7UG1CA189955 -PHI/COG
awarded by
PUBLIC HEALTH INSTITUTE (PHI)
Per Case Reimbursement (PCR)- NIH National Clinical Trails Network (NCTN) Grant (U10CA180886) -PHI/COG
awarded by
PUBLIC HEALTH INSTITUTE (PHI)
Per Case Reimbursement - NIH Pediatric Early Phase Clinical Trials Network Grant (7UM1CA228823-04) - PHI/COG
awarded by
PUBLIC HEALTH INSTITUTE (PHI)
Per Case Reimbursement COG NCORP Research Base
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
Per Case Reimbursement: COG NCORP Research Base
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
Per Case Reimbursement: COG NCORP Research Base
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
Private Grant
awarded by
TERUMO BCT, INC.
Private Grant
awarded by
MILLENNIUM PHARMACEUTICALS, INC.
Private Grant
awarded by
SANCILIO & COMPANY, INC.
Private Grant
awarded by
GLOBAL BLOOD THERAPEUTICS, INC.
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Private Grant
awarded by
GLOBAL BLOOD THERAPEUTICS, INC.
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Project EveryChild APEC14B1
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
Project Everychild APEC14B1
awarded by
CHILDREN'S ONCOLOGY GROUP
Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT Trial)
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT Trial)
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
Quality Improvement Pathway for Newly Diagnosed Immune Thrombocytopenia in Children
awarded by
BOSTON CHILDREN'S HOSPITAL
St. Baldrick's Foundation Supplemental Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
St. Baldricks Fdn Supplemental Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
The COVID-19 Anticoagulation in Children-Thromboprophylaxis (COVAC-TP) Trial
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
The Kids - DOTT Trial
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
Background
Education And Training
UAB Hospital, Internship
UAB Hospital, Residency
UAB Hospital, Postdoctoral Fellowship
Doctor of Medicine,
University of Alabama at Birmingham
2006
Bachelor's Degree in Political Science and Government,
University of Alabama at Birmingham
2001
Contact
Full Name
Christina
Bemrich-Stolz